Minimizing Immunotherapy’s Potentially Harmful Side Effects
Sylvester Comprehensive Cancer CenterNew research from Sylvester Comprehensive Cancer Center indicates that providing prophylactic treatment before immunotherapy can significantly reduce the rate of cytokine release syndrome (CRS) in multiple myeloma patients. Study appears Jan. 4, 2024, in Blood Cancer Discovery.